Поисковый запрос: (<.>S=ПАЛИФЕРМИН<.>) |
Общее количество найденных документов : 17
Показаны документы с 1 по 17
|
1.
| Transient oral cavity and skin complications after mucositis preventing therapy (palifermin) in a patient after allogeneic PBSCT. Case history // Adv. Med. Sci., 2006. Vol. 51, прил. 1.-С.66-68
|
2.
| Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteers // Clin. Pharmacol. and Ther., 2006. Vol. 79, N 6.-С.558-569
|
3.
| Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteers // Clin. Pharmacol. and Ther., 2006. Vol. 79, N 6.-С.558-569
|
4.
| Palifermin and palmar-plantar erythrodysesthesia // Brit. J. Haematol., 2007. Vol. 136, N 6.-С.856-857
|
5.
| Palifermin and palmar-plantar erythrodysesthesia // Brit. J. Haematol., 2007. Vol. 136, N 6.-С.856-857
|
6.
| McDonnell Anne M. Palifermin: Role in the prevention of chemotherapy- and radiation-induced mucositis // Ann. Pharmacother., 2007. Vol. 41, N 1.-С.86-94
|
7.
| McDonnell Anne M. Palifermin: Role in the prevention of chemotherapy- and radiation-induced mucositis // Ann. Pharmacother., 2007. Vol. 41, N 1.-С.86-94
|
8.
| McDonnell Anne M. Palifermin: Role in the prevention of chemotherapy- and radiation-induced mucositis // Ann. Pharmacother., 2007. Vol. 41, N 1.-С.86-94
|
9.
| Gibson Rachel J. Palifermin reduces diarrhea and increases survival following Irinotecan treatment in tumor-bearing DA rats // Int. J. Cancer, 2005. Vol. 116, N 3.-С.464-470
|
10.
| Gibson Rachel J. Palifermin reduces diarrhea and increases survival following Irinotecan treatment in tumor-bearing DA rats // Int. J. Cancer, 2005. Vol. 116, N 3.-С.464-470
|
11.
| Flexural cutaneous eruption due to palifermin // Brit. J. Haematol., 2008. Vol. 140, N 4.-С.464-465
|
12.
| Flexural cutaneous eruption due to palifermin // Brit. J. Haematol., 2008. Vol. 140, N 4.-С.464-465
|
13.
| Blijlevens N. Palifermin (recombinant keratinocyte growth factor-1): A pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis // Ann. Oncol., 2007. Vol. 18, N 5.-С.817-826
|
14.
| Blijlevens N. Palifermin (recombinant keratinocyte growth factor-1): A pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis // Ann. Oncol., 2007. Vol. 18, N 5.-С.817-826
|
15.
| Blijlevens N. Palifermin (recombinant keratinocyte growth factor-1): A pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis // Ann. Oncol., 2007. Vol. 18, N 5.-С.817-826
|
16.
| Blijlevens N. Palifermin (recombinant keratinocyte growth factor-1): A pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis // Ann. Oncol., 2007. Vol. 18, N 5.-С.817-826
|
17.
| Blijlevens N. Palifermin (recombinant keratinocyte growth factor-1): A pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis // Ann. Oncol., 2007. Vol. 18, N 5.-С.817-826
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"